New Drugs and Targets for Asthma and COPD
Imperial College London / National Heart and Lung Institute, Events Office
Archivo
23.11.2011 - 25.11.2011 London
Contenido de curso
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
Objetivos de formación
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals.
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals.
Organizador local
National Heart & Lung Institute
National Heart & Lung Institute
Información e inscripción:
Ms. Karina Dixon
NA
Idioma
Inglés
Inglés
Cantacto organizador
Dovehouse Street
SW3 6LY London
United Kingdom
Dovehouse Street
SW3 6LY London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
